Efficacy of Aripiprazole in Sulpiride-induced Tardive Oromandibular Dystonia

8Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Tardive dystonia is a side effect of dopamine receptor-blocking agents, which are mainly used as antipsychotic drugs. The treatment of tardive dystonia is difficult and often unsuccessful. An 82-year-old woman experienced mandibular deviation to the left due to spasm of the masticatory muscles with involuntary chewing movement and Parkinsonism. She had been treated with sulpiride for motility disorder for 5 years. Parkinsonism almost disappeared after the withdrawal of sulpiride, but tardive oromandibular dystonia showed no improvement. Aripiprazole treatment at 3 mg/day improved tardive oromandibular dystonia without worsening Parkinsonism. Low-dosage aripiprazole may be effective for tardive oromandibular dystonia in patients with no other psychiatric disorder. © 2011, The Japanese Society of Internal Medicine. All rights reserved.

Cite

CITATION STYLE

APA

Imai, N., & Ikawa, M. (2011). Efficacy of Aripiprazole in Sulpiride-induced Tardive Oromandibular Dystonia. Internal Medicine, 50(6), 635–637. https://doi.org/10.2169/internalmedicine.50.4475

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free